Thomson Medical Group Income Statement

Financials in millions SGD. Fiscal year is July - June.

Millions SGD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Revenue	408.67	394.66	351.15	355.77	333.71	240.4
Other Revenue	60.86	60.87	31.5	4.79	4.79	-
Revenue	469.53	455.53	382.65	360.56	338.5	240.4
Revenue Growth (YoY)	13.56%	19.04%	6.13%	6.52%	40.81%	11.23%
Cost of Revenue	248.83	234.82	197.52	177.35	163.24	124.38
Gross Profit	220.7	220.71	185.14	183.21	175.26	116.02
Other Operating Expenses	166.33	166.12	83.24	79.88	65.52	49.25
Operating Expenses	206.77	204.8	111.61	100.95	83.45	67.2
Operating Income	13.92	15.91	73.52	82.26	91.81	48.81
Interest Expense	-53.96	-59.66	-51.55	-30.51	-23.5	-23.61
Interest & Investment Income	2.55	3.62	7.38	3.95	0.99	0.98
Earnings From Equity Investments	-0.01	-0.48	-0.19	-0.49	-	-
EBT Excluding Unusual Items	-37.5	-40.62	29.16	55.2	69.3	26.18
Pretax Income	-37.5	-40.62	29.16	55.2	69.3	26.18
Income Tax Expense	6	6.36	10.94	14.15	10.71	9.27
Earnings From Continuing Operations	-43.5	-46.98	18.21	41.06	58.59	16.91
Net Income to Company	-43.5	-46.98	18.21	41.06	58.59	16.91
Minority Interest in Earnings	-1.43	-0.6	-4.06	-4.5	-4.82	-2.67
Net Income	-44.92	-47.58	14.16	36.56	53.76	14.24
Net Income to Common	-44.92	-47.58	14.16	36.56	53.76	14.24
Net Income Growth	-	-	-61.27%	-32.01%	277.62%	-
Shares Outstanding (Basic)	26,441	26,441	26,441	26,441	26,441	26,441
Shares Outstanding (Diluted)	26,441	26,459	26,459	26,447	26,441	26,441
Shares Change (YoY)	-	-	0.05%	0.02%	-	-
EPS (Basic)	-0.00	-0.00	0.00	0.00	0.00	0.00
EPS (Diluted)	-0.00	-0.00	0.00	0.00	0.00	0.00
EPS Growth	-	-	-61.20%	-32.04%	277.14%	-
Free Cash Flow	45.56	37.87	56.49	77.39	65.05	23.96
Free Cash Flow Per Share	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share	-	-	-	0.000	-	-
Gross Margin	47.00%	48.45%	48.38%	50.81%	51.78%	48.26%
Operating Margin	2.96%	3.49%	19.21%	22.81%	27.12%	20.30%
Profit Margin	-9.57%	-10.44%	3.70%	10.14%	15.88%	5.92%
Free Cash Flow Margin	9.70%	8.31%	14.76%	21.46%	19.22%	9.97%
EBITDA	39.19	41.73	94.14	95.42	102.95	59.54
EBITDA Margin	8.35%	9.16%	24.60%	26.46%	30.41%	24.77%
D&A For EBITDA	25.27	25.82	20.61	13.16	11.14	10.73
EBIT	13.92	15.91	73.52	82.26	91.81	48.81
EBIT Margin	2.96%	3.49%	19.21%	22.81%	27.12%	20.30%
Effective Tax Rate	-	-	37.53%	25.63%	15.46%	35.41%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.